Korro Bio (KRRO) Profit After Tax (2018 - 2026)
Korro Bio (KRRO) posted Profit After Tax of -$19.8 million for Q1 2026, up 60.37% on a QoQ basis from -$50.0 million in Q4 2025, and up 15.2% year-over-year from -$17.2 million in Q1 2025.
Korro Bio (KRRO) Profit After Tax (2018 - 2026) Analysis & Trends
Korro Bio's Profit After Tax history runs 9 years deep, the most recent figure standing at -$19.8 million for Q1 2026.
- Quarterly Profit After Tax rose 15.2% year-over-year to -$19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$113.7 million (down 29.23% YoY) and the FY2025 annual result came in at -$117.3 million, down 40.36% from the prior year.
- Profit After Tax was -$19.8 million for Q1 2026 at Korro Bio, up from -$50.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $6.2 million in Q4 2022 and bottomed at -$50.0 million in Q4 2025.
- A 5-year average of -$21.2 million and a median of -$21.0 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax surged 128.77% — and 2023, when it sank 511.11%.
- Korro Bio's Profit After Tax stood at $6.2 million in 2022, then sank by 511.11% to -$25.4 million in 2023, then increased by 14.38% to -$21.8 million in 2024, then tumbled by 129.84% to -$50.0 million in 2025, then soared by 60.37% to -$19.8 million in 2026.
- Business Quant data shows KRRO's Profit After Tax at -$19.8 million in Q1 2026, -$50.0 million in Q4 2025, and -$18.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -19.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.83 Mn |
| Dec 31, 2025 | -50.04 Mn |
| Sep 30, 2025 | -18.06 Mn |
| Jun 30, 2025 | -25.77 Mn |
| Mar 31, 2025 | -23.39 Mn |
| Dec 31, 2024 | -21.77 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Jun 30, 2024 | -21.83 Mn |
| Mar 31, 2024 | -19.56 Mn |
| Dec 31, 2023 | -25.43 Mn |
| Sep 30, 2023 | -18.49 Mn |
| Jun 30, 2023 | -17.65 Mn |
| Mar 31, 2023 | -19.61 Mn |
| Dec 31, 2022 | 6.19 Mn |
| Sep 30, 2022 | -19.55 Mn |
| Jun 30, 2022 | -21.29 Mn |
| Mar 31, 2022 | -23.39 Mn |
| Dec 31, 2021 | -21.50 Mn |
| Sep 30, 2021 | -25.16 Mn |
| Jun 30, 2021 | -17.66 Mn |